Science
Technology and Economic Assessment Panel reports expected to be produced until 2030 in response to parties’ requests
| Id | Year | Reporting type | Decision | Issue | Request by parties to TEAP | Report to be produced |
|---|---|---|---|---|---|---|
| 0 | 2023 | Progress updates | IV/13 | Technical progress update by TEAP and its TOCs | Decision IV/13 – Report annually to OEWG on technical progress in reducing the use and emissions of controlled substances and assess the use of alternatives, particularly their direct and indirect global-warming effects | 2023 progress report |
| 1 | 2023 | Progress updates | XI/17 | Technical progress update by TEAP and its TOCs | Decision XI/17 – Report on any important new developments on an annual basis | 2023 progress report |
| 2 | 2023 | Progress updates | XXXI/8 | Procedures relevant to nominations to the TEAP and its TOCs. | Decision XXXI/8 – Provide, as part of its annual progress report, a summary outlining the procedures that the Panel and its technical options committees have undertaken to ensure adherence to the Panel’s terms of reference through clear and transparent procedures, including full consultations with the focal points, in line with the terms of reference, regarding: (a) nomination processes, taking into account the matrix of needed expertise and already available expertise; (b) proposed nominations and appointment decisions; (c) termination of appointments; and (d) replacements | 2023 progress report |
| 3 | 2023 | Thematic reports | IX/6 | Critical-use nominations | Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations in accordance with the criteria established in the decision (and other relevant decisions) | 2023 interim report (only upon submission of nominations) |
| 4 | 2023 | Thematic reports | IX/6 | Critical-use nominations | Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations in accordance with the criteria established in the decision (and other relevant decisions) | 2023 final report (only upon submission of nominations) |
| 5 | 2023 | Thematic reports | IV/25 | Essential-use nominations | Decision IV/25 – Review any submitted nominations and make recommendations in accordance with the criteria established in the decision | 2023 progress report (only upon submission of nominations) |
| 6 | 2023 | Thematic reports | XXVIII/2 | Review related to the Kigali Amendment to the Montreal Protocol | Decision XXVIII/2, paragraph 5 – Conduct a technology review four or five years before 2028 to consider a compliance deferral of two years from the freeze date of 2028 for Article 5, group 2, parties to address growth above a certain threshold in several sectors | Report on technology review |
| 7 | 2023 | Thematic reports | XXXI/5 | Laboratory and analytical uses | Decision XXXI/5 – Report in the TEAP quadrennial report on any progress made by parties in reducing their production and consumption of ozone depleting substances for laboratory and analytical uses, on any new alternatives to those uses, and on laboratory standards that can be performed without such substances, on the understanding that, should new compelling information become available, including opportunities for significant reductions in production and consumption, that information should be reported in its annual progress report | 2023 progress report (only if new compelling information becomes available) |
| 8 | 2023 | Thematic reports | XXXI/6 | Process agents | Decision XXXI/6 – Report in the TEAP quadrennial reports on any progress made by parties in reducing their use and emissions of controlled substances as process agents and on any new alternatives to such uses, including new production processes and emissions-reduction techniques, on the understanding that should new compelling information become available, that information should be reported in its annual progress report | 2023 progress report (only if new compelling information becomes available) |
| 9 | 2023 | Thematic reports | XXX/15 | Process agents; destruction technologies; laboratory and analytical uses; n-propyl bromide; possible new substances | Review only if the specific conditions set out in decision XXX/15 are met | |
| 10 | 2023 | Thematic reports | XXXIV/3 | Energy efficiency and low or zero GWP technologies | Decision XXXIV/3 - To include in the progress report information set out in paragraph 1 (a) of the decision | 2023 progress report |
| 11 | 2023 | Thematic reports | XXXIV/5 | Atmospheric Monitoring of controlled substances | Decision XXXIV/5: To prepare a report for the 44th OEWG meeting on (a) Chemical pathways in which substantial emissions of controlled substances are likely to occur; (b) best practices available to control these emissions; (c) gaps in understanding the sources of emissions referred to in point (a) above | Report on the identification of gaps in the global coverage of atmospheric monitoring of controlled substances and options for enhancing such monitoring |
| 12 | 2023 | Thematic reports | XXXIV/6 | Carbon tetrachloride emissions | Decision XXXIV/6: review the information submitted by parties on the national procedures and frameworks in place for management of production activities, and present this information in its 2023 progress report for consideration by the OEWG at its 45th meeting | 2023 progress report |
| 13 | 2023 | Thematic reports | XXXIV/7 | HFC-23 by-product emissions | Decision XXXIV/7: prepare a report for the 35th MOP to include: (a) Information on the possible chemical pathways that could be used in the production of Annex C, Group I, or Annex F substances that may generate HFC-23 as a by-product; (b) compilation of information on the amount of HFC-23 generation and emissions from facilities that manufacture Annex C, Group I, or Annex F substances; (c) best practices available to control these emissions | Report on strengthening institutional process on HFC-23 by-product emissions |
| 14 | 2023 | Thematic reports | XXXIV/10 | Methyl bromide stocks and quarantine and pre-shipment (QPS) uses | Decision XXXIV/10: provide, in consultation with the secretariat of the International Plant Protection Convention, updated information, as part of its progress report on current quarantine and pre-shipment uses for which alternatives are available | 2023 progress report |
| 15 | 2023 | Thematic reports | XXXIV/11 | Composition, balance and workload of TEAP and its TOCs | Decision XXXIV/11: provide more information on existing challenges and potential options for the future configuration and function of its technical options committees, for consideration by OEWG at its 45th meeting, as set out in paragraph 1(a) of the decision | 2023 progress report |
| 16 | 2023 | Periodic assessments | XXXIV/2 | Replenishment study for 2024–2026 | Decision XXXIV/2: Prepare a report for submission to the 35th MOP to adopt a decision on the appropriate level of the 2024–2026 replenishment of the Multilateral Fund | Replenishment task force report (2024–2026) |
| 17 | 2023 | Periodic assessments | XXXIV/2 | Replenishment study for 2024–2026 | Decision XXXIV/2: Prepare a report for submission to the 35th MOP to adopt a decision on the appropriate level of the 2024–2026 replenishment of the Multilateral Fund | Supplement to the replenishment task force report |
| 18 | 2023 | Periodic assessments | XXXI/2 | Quadrennial assessment | Decision XXXI/2: Prepare the assessment panels’ synthesis report | 2022 quadrennial assessment synthesis report |
| 19 | 2024 | Progress updates | IV/13 | Technical progress update by TEAP and its TOCs | Decision IV/13 – Report annually to OEWG on technical progress in reducing the use and emissions of controlled substances and assess the use of alternatives, particularly their direct and indirect global-warming effects | 2024 progress report |
| 20 | 2024 | Progress updates | XI/17 | Technical progress update by TEAP and its TOCs | Decision XI/17 – Report on any important new developments on an annual basis | 2024 progress report |
| 21 | 2024 | Progress updates | XXXI/8 | Procedures relevant to nominations to the TEAP and its TOCs. | Decision XXXI/8 – Provide, as part of its annual progress report, a summary outlining the procedures that the Panel and its technical options committees have undertaken to ensure adherence to the Panel’s terms of reference through clear and transparent procedures, including full consultations with the focal points, in line with the terms of reference, regarding: (a) nomination processes, taking into account the matrix of needed expertise and already available expertise; (b) proposed nominations and appointment decisions; (c) termination of appointments; and (d) replacements | 2024 progress report |
| 22 | 2024 | Thematic reports | IX/6 | Critical-use nominations | Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) | 2024 interim report (only upon submission of nominations) |
| 23 | 2024 | Thematic reports | IX/6 | Critical-use nominations | Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) | 2024 final report (only upon submission of nominations) |
| 24 | 2024 | Thematic reports | IV/25 | Essential-use nominations | Decision IV/25 – Review any submitted nominations and make recommendations in accordance with the criteria established in the decision | 2024 progress report (only upon submission of nominations) |
| 25 | 2024 | Thematic reports | XXVIII/2 | Review related to the Kigali Amendment to the Montreal Protocol | Decision XXVIII/2, paragraph 5 – Conduct a technology review four or five years before 2028 to consider a compliance deferral of two years from the freeze date of 2028 for Article 5, group 2, parties to address growth above a certain threshold in several sectors | Report on technology review |
| 26 | 2024 | Thematic reports | XXXI/5 | Laboratory and analytical uses | Decision XXXI/5 – Report in the TEAP quadrennial report on any progress made by parties in reducing their production and consumption of ozone depleting substances for laboratory and analytical uses, on any new alternatives to those uses, and on laboratory standards that can be performed without such substances, on the understanding that, should new compelling information become available, including opportunities for significant reductions in production and consumption, that information should be reported in its annual progress report | 2024 progress report (only if new compelling information becomes available) |
| 27 | 2024 | Thematic reports | XXXI/6 | Process agents | Decision XXXI/6 – Report in the TEAP quadrennial reports on any progress made by parties in reducing their use and emissions of controlled substances as process agents and on any new alternatives to such uses, including new production processes and emissions-reduction techniques, on the understanding that should new compelling information become available, that information should be reported in its annual progress report | 2024 progress report (only if new compelling information becomes available) |
| 28 | 2024 | Thematic reports | XXX/15 | Process agents; destruction technologies; laboratory and analytical uses; n-propyl bromide; possible new substances | Review only if the specific conditions set out in decision XXX/15 are met | |
| 29 | 2025 | Progress updates | IV/13 | Technical progress update by TEAP and its TOCs | Decision IV/13 – Report annually to OEWG on technical progress in reducing the use and emissions of controlled substances and assess the use of alternatives, particularly their direct and indirect global-warming effects | 2025 progress report |
| 30 | 2025 | Progress updates | XI/17 | Technical progress update by TEAP and its TOCs | Decision XI/17 – Report on any important new developments on an annual basis | 2025 progress report |
| 31 | 2025 | Progress updates | XXXI/8 | Procedures relevant to nominations to the TEAP and its TOCs. | Decision XXXI/8 – Provide, as part of its annual progress report, a summary outlining the procedures that the Panel and its technical options committees have undertaken to ensure adherence to the Panel’s terms of reference through clear and transparent procedures, including full consultations with the focal points, in line with the terms of reference, regarding: (a) nomination processes, taking into account the matrix of needed expertise and already available expertise; (b) proposed nominations and appointment decisions; (c) termination of appointments; and (d) replacements | 2025 progress report |
| 32 | 2025 | Thematic reports | IX/6 | Critical-use nominations | Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) | 2025 interim report (only upon submission of nominations) |
| 33 | 2025 | Thematic reports | IX/6 | Critical-use nominations | Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) | 2025 final report (only upon submission of nominations) |
| 34 | 2025 | Thematic reports | IV/25 | Essential-use nominations | Decision IV/25 – Review any submitted nominations and make recommendations in accordance with the criteria established in the decision | 2025 progress report (only upon submission of nominations) |
| 35 | 2025 | Thematic reports | XXXI/5 | Laboratory and analytical uses | Decision XXXI/5 – Report in the TEAP quadrennial report on any progress made by parties in reducing their production and consumption of ozone depleting substances for laboratory and analytical uses, on any new alternatives to those uses, and on laboratory standards that can be performed without such substances, on the understanding that, should new compelling information become available, including opportunities for significant reductions in production and consumption, that information should be reported in its annual progress report | 2025 progress report (only if new compelling information becomes available) |
| 36 | 2025 | Thematic reports | XXXI/6 | Process agents | Decision XXXI/6 – Report in the TEAP quadrennial reports on any progress made by parties in reducing their use and emissions of controlled substances as process agents and on any new alternatives to such uses, including new production processes and emissions-reduction techniques, on the understanding that should new compelling information become available, that information should be reported in its annual progress report | 2025 progress report (only if new compelling information becomes available) |
| 37 | 2025 | Thematic reports | XXX/15 | Process agents; destruction technologies; laboratory and analytical uses; n-propyl bromide; possible new substances | Review only if the specific conditions set out in decision XXX/15 are met | |
| 38 | 2026 | Progress updates | IV/13 | Technical progress update by TEAP and its TOCs | Decision IV/13 – Report annually to OEWG on technical progress in reducing the use and emissions of controlled substances and assess the use of alternatives, particularly their direct and indirect global-warming effects | 2026 progress report |
| 39 | 2026 | Progress updates | XI/17 | Technical progress update by TEAP and its TOCs | Decision XI/17 – Report on any important new developments on an annual basis | 2026 progress report |
| 40 | 2026 | Progress updates | XXXI/8 | Procedures relevant to nominations to the TEAP and its TOCs. | Decision XXXI/8 – Provide, as part of its annual progress report, a summary outlining the procedures that the Panel and its technical options committees have undertaken to ensure adherence to the Panel’s terms of reference through clear and transparent procedures, including full consultations with the focal points, in line with the terms of reference, regarding: (a) nomination processes, taking into account the matrix of needed expertise and already available expertise; (b) proposed nominations and appointment decisions; (c) termination of appointments; and (d) replacements | 2026 progress report |
| 41 | 2026 | Thematic reports | IX/6 | Critical-use nominations | Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) | 2026 interim report (only upon submission of nominations) |
| 42 | 2026 | Thematic reports | IX/6 | Critical-use nominations | Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) | 2026 final report (only upon submission of nominations) |
| 43 | 2026 | Thematic reports | IV/25 | Essential-use nominations | Decision IV/25 – Review any submitted nominations and make recommendations in accordance with the criteria established in the decision | 2026 progress report (only upon submission of nominations) |
| 44 | 2026 | Thematic reports | XXXI/5 | Laboratory and analytical uses | Decision XXXI/5 – Report in the TEAP quadrennial report on any progress made by parties in reducing their production and consumption of ozone depleting substances for laboratory and analytical uses, on any new alternatives to those uses, and on laboratory standards that can be performed without such substances, on the understanding that, should new compelling information become available, including opportunities for significant reductions in production and consumption, that information should be reported in its annual progress report | TEAP 2026 quadrennial assessment report |
| 45 | 2026 | Thematic reports | XXXI/6 | Process agents | Decision XXXI/6 – Report in the TEAP quadrennial reports on any progress made by parties in reducing their use and emissions of controlled substances as process agents and on any new alternatives to such uses, including new production processes and emissions-reduction techniques, on the understanding that should new compelling information become available, that information should be reported in its annual progress report | TEAP 2026 quadrennial assessment reports |
| 46 | 2026 | Thematic reports | XXX/15 | Process agents; destruction technologies; laboratory and analytical uses; n-propyl bromide; possible new substances | Review only if the specific conditions set out in decision XXX/15 are met | |
| 47 | 2026 | Periodic assessments | Replenishment study for 2027–2029 | Expected decision at the 37th MOP, in 2025, and potential additional guidance by OEWG (48th meeting) in 2026 – Prepare a report on the appropriate level of the 2027–2029 replenishment of the Multilateral Fund | Replenishment task force report (2027–2029) | |
| 48 | 2026 | Periodic assessments | Replenishment study for 2027–2029 | Expected decision at the 37th MOP, in 2025, and potential additional guidance by OEWG (48th meeting) in 2026 – Prepare a report on the appropriate level of the 2027–2029 replenishment of the Multilateral Fund | Supplement to the replenishment task force report | |
| 49 | 2026 | Periodic assessments | Quadrennial assessment | Expected decision at the 35th MOP, in 2023 – Prepare the TEAP 2026 quadrennial assessment | TEAP and TOCs 2026 quadrennial assessment reports (6) | |
| 50 | 2026 | Periodic assessments | XXIX/12 | HFCs not listed in Annex F of the Montreal Protocol | Decision XXIX/12 – Provide in the quadrennial reports of the assessment panels to be presented to the 35th MOP, in 2023, and every four years thereafter, information on the consumption and production of HFCs not listed in Annex F of the Protocol that have global warming potential no less than the lowest global warming potential of the HFCs listed in Annex F | TEAP and TOCs 2026 quadrennial assessment reports (6) |
| 51 | 2026 | Periodic assessments | XXX/2 | HCFC availability | Decision XXX/2 – Provide in its quadrennial reports to be presented to the 35th MOP, in 2023, and to the 39th MOP, in 2027, information on the availability of Annex C, group I, substances, including amounts available from recovery, recycling and reclamation, and best available information on country-level and total known stocks, as well as the availability of alternative options for the applications described in Article 2F, paragraphs 6 (a) and 6 (b) | TEAP and TOCs 2026 quadrennial assessment reports (6) |
| 52 | 2027 | Progress updates | IV/13 | Technical progress update by TEAP and its TOCs | Decision IV/13 – Report annually to OEWG on technical progress in reducing the use and emissions of controlled substances and assess the use of alternatives, particularly their direct and indirect global-warming effects | 2027 progress report |
| 53 | 2027 | Progress updates | XI/17 | Technical progress update by TEAP and its TOCs | Decision XI/17 – Report on any important new developments on an annual basis | 2027 progress report |
| 54 | 2027 | Progress updates | XXXI/8 | Procedures relevant to nominations to the TEAP and its TOCs. | Decision XXXI/8 – Provide, as part of its annual progress report, a summary outlining the procedures that the Panel and its technical options committees have undertaken to ensure adherence to the Panel’s terms of reference through clear and transparent procedures, including full consultations with the focal points, in line with the terms of reference, regarding: (a) nomination processes, taking into account the matrix of needed expertise and already available expertise; (b) proposed nominations and appointment decisions; (c) termination of appointments; and (d) replacements | 2027 progress report |
| 55 | 2027 | Thematic reports | IX/6 | Critical-use nominations | Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) | 2027 interim report (only upon submission of nominations) |
| 56 | 2027 | Thematic reports | IX/6 | Critical-use nominations | Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) | 2027 final report (only upon submission of nominations) |
| 57 | 2027 | Thematic reports | IV/25 | Essential-use nominations | Decision IV/25 – Review any submitted nominations and make recommendations in accordance with the criteria established in the decision | 2027 progress report (only upon submission of nominations) |
| 58 | 2027 | Thematic reports | XXXI/5 | Laboratory and analytical uses | Decision XXXI/5 – Report in the TEAP quadrennial report on any progress made by parties in reducing their production and consumption of ozone depleting substances for laboratory and analytical uses, on any new alternatives to those uses, and on laboratory standards that can be performed without such substances, on the understanding that, should new compelling information become available, including opportunities for significant reductions in production and consumption, that information should be reported in its annual progress report | 2027 progress report (only if new compelling information becomes available) |
| 59 | 2027 | Thematic reports | XXXI/6 | Process agents | Decision XXXI/6 – Report in the TEAP quadrennial reports on any progress made by parties in reducing their use and emissions of controlled substances as process agents and on any new alternatives to such uses, including new production processes and emissions-reduction techniques, on the understanding that should new compelling information become available, that information should be reported in its annual progress report | 2027 progress report (only if new compelling information becomes available) |
| 60 | 2027 | Thematic reports | XXX/15 | Process agents; destruction technologies; laboratory and analytical uses; n-propyl bromide; possible new substances | Review only if the specific conditions set out in decision XXX/15 are met | |
| 61 | 2027 | Periodic assessments | Quadrennial assessment | Expected decision at the 35th MOP, in 2023 – Prepare the assessment panels’ synthesis report | 2026 quadrennial assessment synthesis report | |
| 62 | 2027 | Periodic assessments | XXVIII/2 | Review related to the Kigali Amendment to the Montreal Protocol | Decision XXVIII/2, paragraph 4 – Conduct periodic reviews of alternatives to HFCs in 2022 and every five years thereafter, and provide technological and economic assessments of the latest available and emerging alternatives to HFCs (second review) | Report on review of alternatives to HFCs |
| 63 | 2028 | Progress updates | IV/13 | Technical progress update by TEAP and its TOCs | Decision IV/13 – Report annually to OEWG on technical progress in reducing the use and emissions of controlled substances and assess the use of alternatives, particularly their direct and indirect global-warming effects | 2028 progress report |
| 64 | 2028 | Progress updates | XI/17 | Technical progress update by TEAP and its TOCs | Decision XI/17 – Report on any important new developments on an annual basis | 2028 progress report |
| 65 | 2028 | Progress updates | XXXI/8 | Procedures relevant to nominations to the TEAP and its TOCs. | Decision XXXI/8 – Provide, as part of its annual progress report, a summary outlining the procedures that the Panel and its technical options committees have undertaken to ensure adherence to the Panel’s terms of reference through clear and transparent procedures, including full consultations with the focal points, in line with the terms of reference, regarding: (a) nomination processes, taking into account the matrix of needed expertise and already available expertise; (b) proposed nominations and appointment decisions; (c) termination of appointments; and (d) replacements | 2028 progress report |
| 66 | 2028 | Thematic reports | IX/6 | Critical-use nominations | Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) | 2028 interim report (only upon submission of nominations) |
| 67 | 2028 | Thematic reports | IX/6 | Critical-use nominations | Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) | 2028 final report (only upon submission of nominations) |
| 68 | 2028 | Thematic reports | IV/25 | Essential-use nominations | Decision IV/25 – Review any submitted nominations and make recommendations in accordance with the criteria established in the decision | 2028 progress report (only upon submission of nominations) |
| 69 | 2028 | Thematic reports | XXXI/5 | Laboratory and analytical uses | Decision XXXI/5 – Report in the TEAP quadrennial report on any progress made by parties in reducing their production and consumption of ozone depleting substances for laboratory and analytical uses, on any new alternatives to those uses, and on laboratory standards that can be performed without such substances, on the understanding that, should new compelling information become available, including opportunities for significant reductions in production and consumption, that information should be reported in its annual progress report | 2028 progress report (only if new compelling information becomes available) |
| 70 | 2028 | Thematic reports | XXXI/6 | Process agents | Decision XXXI/6 – Report in the TEAP quadrennial reports on any progress made by parties in reducing their use and emissions of controlled substances as process agents and on any new alternatives to such uses, including new production processes and emissions-reduction techniques, on the understanding that should new compelling information become available, that information should be reported in its annual progress report | 2028 progress report (only if new compelling information becomes available) |
| 71 | 2028 | Thematic reports | XXX/15 | Process agents; destruction technologies; laboratory and analytical uses; n-propyl bromide; possible new substances | Review only if the specific conditions set out in decision XXX/15 are met | |
| 72 | 2028 | Periodic assessments | XXVIII/2 | Review related to the Kigali Amendment to the Montreal Protocol | Decision XXVIII/2, paragraphs 32 and 33 – Periodically assess the suitability of HFC alternatives for use at high ambient temperatures, starting four years from the HFC freeze date and every four years thereafter (first review) | Assessment of high-ambient-temperature HFC alternatives |
| 73 | 2029 | Progress updates | IV/13 | Technical progress update by TEAP and its TOCs | Decision IV/13 – Report annually to OEWG on technical progress in reducing the use and emissions of controlled substances and assess the use of alternatives, particularly their direct and indirect global-warming effects | 2029 progress report |
| 74 | 2029 | Progress updates | XI/17 | Technical progress update by TEAP and its TOCs | Decision XI/17 – Report on any important new developments on an annual basis | 2029 progress report |
| 75 | 2029 | Progress updates | XXXI/8 | Procedures relevant to nominations to the TEAP and its TOCs. | Decision XXXI/8 – Provide, as part of its annual progress report, a summary outlining the procedures that the Panel and its technical options committees have undertaken to ensure adherence to the Panel’s terms of reference through clear and transparent procedures, including full consultations with the focal points, in line with the terms of reference, regarding: (a) nomination processes, taking into account the matrix of needed expertise and already available expertise; (b) proposed nominations and appointment decisions; (c) termination of appointments; and (d) replacements | 2029 progress report |
| 76 | 2029 | Thematic reports | IX/6 | Critical-use nominations | Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) | 2029 interim report (only upon submission of nominations) |
| 77 | 2029 | Thematic reports | IX/6 | Critical-use nominations | Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) | 2029 final report (only upon submission of nominations) |
| 78 | 2029 | Thematic reports | IV/25 | Essential-use nominations | Decision IV/25 – Review any submitted nominations and make recommendations in accordance with the criteria established in the decision | 2029 progress report (only upon submission of nominations) |
| 79 | 2029 | Thematic reports | XXXI/5 | Laboratory and analytical uses | Decision XXXI/5 – Report in the TEAP quadrennial report on any progress made by parties in reducing their production and consumption of ozone depleting substances for laboratory and analytical uses, on any new alternatives to those uses, and on laboratory standards that can be performed without such substances, on the understanding that, should new compelling information become available, including opportunities for significant reductions in production and consumption, that information should be reported in its annual progress report | 2029 progress report (only if new compelling information becomes available) |
| 80 | 2029 | Thematic reports | XXXI/6 | Process agents | Decision XXXI/6 – Report in the TEAP quadrennial reports on any progress made by parties in reducing their use and emissions of controlled substances as process agents and on any new alternatives to such uses, including new production processes and emissions-reduction techniques, on the understanding that should new compelling information become available, that information should be reported in its annual progress report | 2029 progress report (only if new compelling information becomes available) |
| 81 | 2029 | Thematic reports | XXX/15 | Process agents; destruction technologies; laboratory and analytical uses; n-propyl bromide; possible new substances | Review only if the specific conditions set out in decision XXX/15 are met | |
| 82 | 2029 | Periodic assessments | Replenishment study for 2030–2032 | Expected decision at the 40th MOP, in 2028, and potential additional guidance by OEWG (51st meeting) in 2029 – Prepare a report on the appropriate level of the 2030–2032 replenishment of the Multilateral Fund | Replenishment task force report (2030–2032) | |
| 83 | 2029 | Periodic assessments | Replenishment study for 2030–2032 | Expected decision at the 40th MOP, in 2028, and potential additional guidance by OEWG (51st meeting) in 2029 – Prepare a report on the appropriate level of the 2030–2032 replenishment of the Multilateral Fund | Supplement to the replenishment task force report | |
| 84 | 2030 | Progress updates | IV/13 | Technical progress update by TEAP and its TOCs | Decision IV/13 – Report annually to OEWG on technical progress in reducing the use and emissions of controlled substances and assess the use of alternatives, particularly their direct and indirect global-warming effects | 2030 progress report |
| 85 | 2030 | Progress updates | XI/17 | Technical progress update by TEAP and its TOCs | Decision XI/17 – Report on any important new developments on an annual basis | 2030 progress report |
| 86 | 2030 | Progress updates | XXXI/8 | Procedures relevant to nominations to the TEAP and its TOCs. | Decision XXXI/8 – Provide, as part of its annual progress report, a summary outlining the procedures that the Panel and its technical options committees have undertaken to ensure adherence to the Panel’s terms of reference through clear and transparent procedures, including full consultations with the focal points, in line with the terms of reference, regarding: (a) nomination processes, taking into account the matrix of needed expertise and already available expertise; (b) proposed nominations and appointment decisions; (c) termination of appointments; and (d) replacements | 2030 progress report |
| 87 | 2030 | Thematic reports | IX/6 | Critical-use nominations | Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) | 2030 interim report (only upon submission of nominations) |
| 88 | 2030 | Thematic reports | IX/6 | Critical-use nominations | Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) | 2030 final report (only upon submission of nominations) |
| 89 | 2030 | Thematic reports | IV/25 | Essential-use nominations | Decision IV/25 – Review any submitted nominations and make recommendations in accordance with the criteria established in the decision | 2030 progress report (only upon submission of nominations) |
| 90 | 2030 | Thematic reports | XXXI/5 | Laboratory and analytical uses | Decision XXXI/5 – Report in the TEAP quadrennial report on any progress made by parties in reducing their production and consumption of ozone depleting substances for laboratory and analytical uses, on any new alternatives to those uses, and on laboratory standards that can be performed without such substances, on the understanding that, should new compelling information become available, including opportunities for significant reductions in production and consumption, that information should be reported in its annual progress report | TEAP 2030 quadrennial assessment report |
| 91 | 2030 | Thematic reports | XXXI/6 | Process agents | Decision XXXI/6 – Report in the TEAP quadrennial reports on any progress made by parties in reducing their use and emissions of controlled substances as process agents and on any new alternatives to such uses, including new production processes and emissions-reduction techniques, on the understanding that should new compelling information become available, that information should be reported in its annual progress report | TEAP 2030 quadrennial assessment report |
| 92 | 2030 | Thematic reports | XXX/15 | Process agents; destruction technologies; laboratory and analytical uses; n-propyl bromide; possible new substances | Review only if the specific conditions set out in decision XXX/15 are met | |
| 93 | 2030 | Periodic assessments | Quadrennial assessment | Expected decision at the 39th MOP, in 2027 - Prepare the TEAP 2030 quadrennial assessment | TEAP and TOCs 2030 quadrennial assessment reports (6) | |
| 94 | 2030 | Periodic assessments | XXIX/12 | HFCs not listed in Annex F of the Montreal Protocol | Decision XXIX/12 – Provide in the quadrennial reports of the assessment panels to be presented to the 35th MOP, in 2023, and every four years thereafter, information on the consumption and production of HFCs not listed in Annex F of the Protocol that have global warming potential no less than the lowest global warming potential of the HFCs listed in Annex F | TEAP and TOCs 2030 quadrennial assessment reports (6) |
1 In case the review in response to decision XXVIII/2, para. 5, is conducted five years before 2028.
2 The provisions of decision XXX/15 regarding process agents and laboratory and analytical uses are superceded by decisions XXXI/6 and XXXI/5, respectively. The process of dealing with possible new substances is set out in decision IX/24.
3 Reports to be produced on the listed issues are not indicated herein given that the time at which the respective conditions set out in decision XXX/15 will be met is not known.
4 In case the review in response to decision XXVIII/2, para. 5, is conducted four years before 2028.